[R21] Use of scnn1b transgenic mice to develop new vaccines against pulmonary Mycobacterium avium
Ente: National Institute of Allergy and Infectious Diseases
Scadenza: 2028-05-31
Importo max: $423,500
Paese: US
Descrizione
Over the past fifteen years, there has been an increase in the prevalence of pulmonary nontuberculous mycobacteria
(NTM) in the US and other developed countries. Patients with underlying lung diseases such as chronic obstructive lung
disease (COPD) and cystic fibrosis (CF) are at increased risk of d
Settori: National Institute of Allergy and Infectious Diseases
Registrati gratis su Bandolo per trovare bandi compatibili con la tua azienda.